skip to Main Content

Bacteria on Tumors Influences Immune Response and Survival of Patients with Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
A key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response, a team led by researchers from The University of Texas MD Anderson Cancer Center reports in the journal Cell.

The researchers also showed that fecal microbiota transplants (FMT) from long-term survivors prompted immune response and stifled tumors in a mouse model of the disease by altering the bacteria on the tumor – its microbiome. Read more . . . 

Back To Top